Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation - Concepedia

Concepedia

Publication | Closed Access

Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation

98

Citations

29

References

2007

Year

Daniel Albrecht, Elizabeth A. Clubbs, Mário G. Ferruzzi, Joshua A. Bomser

Chemico-Biological Interactions

OncologyMedicineMek-independent Erk1/2 ActivationAnti-cancer AgentProstatic DiseasePharmacologyCell BiologyCell SignalingTumor BiologyCancer Growth

References

	Year	Citations

Page 1